Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1387508 NEW YORK, NY

Position in ROIV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,091,126
+$475,951 QoQ
Shares Held
111,593
-7.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $75,046,663 across 96 Biotechnology names. ROIV ranks #5 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ROIV
Roivant Sciences Ltd.
This page
111,593 $3,091,126

All Filings in ROIV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,091,126 111,593
2025-12-31 $2,615,175 120,515
2025-09-30 $1,226,740 81,080
2025-06-30 $1,857,070 164,780
2025-03-31 $2,669,814 264,600
2024-12-31 $2,897,640 244,940
2024-09-30 $3,163,921 274,170
2024-06-30 $2,772,278 262,278
2024-03-31 $2,811,608 266,756
2023-12-31 $204,397 18,201
2023-09-30 $260,230 22,280
2023-06-30 $496,944 49,300
2023-03-31 $301,104 40,800
2022-12-31 $168,589 21,100